Robert Blum is the President and CEO of Cytokinetics, Inc., a biopharmaceutical company focused on muscle biology and specialty heart disease.
Robert Blum is the President and CEO of Cytokinetics, Inc., a biopharmaceutical company focused on muscle biology and specialty heart disease. He leads the company's development of potential new medicines for cardiovascular conditions and has overseen strategy including planned regulatory submissions and direct commercial activities.
Full founder directory · Investor directory · Company funding database · Fundraising library